Germ cell tumors: An update of recent data and review of active protocols in stage I and metastatic disease

被引：5

作者：

Hahn, NM ^{[1
]}

Sweeney, CJ ^{[1
]}

机构：

[1] Indiana Univ, Dept Haematol & Med Oncol, Indianapolis, IN 46202 USA

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2005年 / 23卷 / 04期

关键词：

germ cell tumor; seminoma; nonseminoma; stage I; metastases; update; clinical trials; evidence;

D O I：

10.1016/j.urolonc.2005.05.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Germ cell tumors are highly curable malignancies even when metastatic. Investigations currently focus on curtailing toxicity in low-fisk patients and improving cure rates in poor-risk individuals. Reduced dose radiation schedules and short-course chemotherapy regimens have been evaluated in stage I disease. In metastatic disease, several new nonplatinum agents offer promise for patients with poor risk or relapsed disease. In addition, high-dose chemotherapy regimens with autologous stem cell transplant provide potential for further improvements in survival. This review will highlight recent developments and currently active clinical trials pertinent to the treatment of patients with germ cell tumors. (c) 2005 Elsevier Inc. All rights reserved.

引用

页码：293 / 302

页数：10

共 61 条

[1] Treatment of recurrent cervical adenocarcinoma with BMS-247550, an epothilone B analog [J].

Agrawal, M ;

Edgerly, M ;

Fojo, T ;

Kotz, H .

GYNECOLOGIC ONCOLOGY, 2003, 90 (01) :96-99

[2]

ALEXANDRE J, 2000, P AM SOC CLIN ONCOL

[3]

[Anonymous], CANC FACTS FIG 2004

[4] Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: A long-term update [J].

Bhayani, SB ;

Ong, A ;

Oh, WK ;

Kantoff, PW ;

Kavoussi, LR .

UROLOGY, 2003, 62 (02) :324-327

[5]

Bokemeyer C, 1996, ANN ONCOL, V7, P31

[6] Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer [J].

Bokemeyer, C ;

Gerl, A ;

Schöffski, P ;

Harstrick, A ;

Niederle, N ;

Beyer, J ;

Casper, J ;

Schmoll, HJ ;

Kanz, L .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :512-516

[7] Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: A medical research council report [J].

Cullen, MH ;

Stenning, SP ;

Parkinson, MC ;

Fossa, SD ;

Kaye, SB ;

Horwich, AH ;

Harland, SJ ;

Williams, MV ;

Jakes, R .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1106-1113

[8] Gefitinib [J].

Culy, CR ;

Faulds, D .

DRUGS, 2002, 62 (15) :2237-2248

[9]

*DAYT CLIN ONC PRO, SCHEM

[10]

de Wit R, 1999, INT J CANCER, V83, P831, DOI 10.1002/(SICI)1097-0215(19991210)83:6<831::AID-IJC24>3.0.CO

← 1 2 3 4 5 6 7 →